Abiopharma

🔍 Blue Holdings Sponsor LLC (Executive)

Company: Blue Acquisition Corp/Cayman (BACC)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Acquired 391,000 shares of Class A ordinary shares (Direct)
  Date: 2025-06-16 | Code: P | equity_swap_involved: 0 | shares_owned_after: 391,000.00 | transaction_form_type: 4 | Footnotes: F3, F1, F3, F3

Footnotes:

• F1: This filing is being made solely to reflect a change in the beneficial owner of securities held by Blue Holdings Sponsor LLC ("Sponsor"). On June 16, 2026, Ketan Seth, the former Chief Executive Officer of the Issuer (a position from which Mr. Seth resigned as of June 9, 2026), resigned from his position as the managing member of Blue Holdings Management LLC ("BHM"), the managing member of the Sponsor, and forfeited and surrendered to BHM any and all rights, tile or interest in and to any membership units of BHM and any securities of the Issuer, including, without limitation, any right, title or interest to or in any securities of the surviving public company upon and after the consummation (the "Closing"), if any, of the proposed business combination transaction between the Issuer and Blockfusion USA, Inc.
• F2: Upon the resignation and forfeiture by Ketan Seth, David Bauer, the Issuer's interim Chief Executive Officer and Chief Financial Officer, was appointed as the managing member of BHM and holds voting and investment discretion with respect to the securities held of record by the Sponsor. As such, Mr. Bauer may be deemed to have beneficial ownership of the securities held of record by the Sponsor. Mr. Bauer disclaims any beneficial ownership except to the extent of his pecuniary interest therein.
• F3: Reflects the 391,000 Class A ordinary shares of Blue Acquisition Corp. (the "Issuer") that are included in the 391,000 private placement units of the Issuer purchased by Blue Holdings Sponsor LLC ("Sponsor"). Each private placement unit was purchased for $10 per unit and consists of one Class A ordinary share and one right to receive one-tenth (1/10) of one Class A ordinary share upon consummation of the Issuer's initial business combination.